What's New

Last Posted: May 25, 2023

• Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.
  Laney K Jones et al. Front Health Serv 2023 31104311
• Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry.
  Poranee Ganokroj et al. J Atheroscler Thromb 2023
• Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias.
  Michal Vrablík et al. PLoS One 2023 18(5) e0272883
• Screening for 3 Genetic Conditions Is Cost-effective in Younger People.
  Emily Harris et al. JAMA 2023 5
• Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia.
  Elena Olmastroni et al. J Am Heart Assoc 2023 e029223
• Genetic Testing Enables the Diagnosis of Familial Hypercholesterolemia Underdiagnosed by Clinical Criteria: Analysis of Japanese Early-Onset Coronary Artery Disease Patients.
  Hiroshi Miyama et al. Cardiol Res Pract 2023 20232236422
• Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolaemia using FAMCAT Primary Care Screening Tool: A Mixed-Methods Evaluation Study Protocol.
  Anis Safura Ramli et al. JMIR Res Protoc 2023
• Population Genomic Screening for Three Common Hereditary Conditions : A Cost-Effectiveness Analysis.
  Gregory F Guzauskas et al. Ann Intern Med 2023 5
• Familial Hypercholesterolemia: The Atlantic Divide.
  Samuel S Gidding et al. J Pediatr 2022 9
• New Family Heart Foundation Study Reveals Systemic Underdiagnosis & Undertreatment of HoFH
  Family Heart Foundation, May 2, 2023
• A comparison of the Netherlands, Norway and UK familial hypercholesterolemia screening programmes with implications for target setting and the UK's NHS long term plan.
  Christopher Page et al. PLOS Glob Public Health 2023 3(4) e0001795
• Addressing the underdiagnosis of familial hypercholesterolemia: A mixed methods study exploring the knowledge and practice behaviors of cardiology healthcare providers.
  Isha Kalia et al. J Clin Transl Sci 2023 7(1) e92
• Contemporary Homozygous Familial Hypercholesterolemia in the United States: Insights From the CASCADE FH Registry.
  Marina Cuchel et al. J Am Heart Assoc 2023 4 e029175
• Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands.
  Zanfina Ademi et al. JAMA Pediatr 2023 5
• Familial Hypercholesterolemia in the Electronic Medical Records and Genomics Network: Prevalence, Penetrance, Cardiovascular Risk, and Outcomes After Return of Results.
  Ozan Dikilitas et al. Circ Genom Precis Med 2023 16(2) e003816
• LDL cholesterol targets rarely achieved in familial hypercholesterolemia patients: A sex and gender-specific analysis.
  M M Schreuder et al. Atherosclerosis
• Enhancing the Detection and Care of Heterozygous Familial Hypercholesterolemia in Primary Care: Cost-Effectiveness and Return on Investment.
  Clara Marquina et al. Circ Genom Precis Med 2023 e003842
• Genetic Testing for Familial Hypercholesterolemia in Clinical Practice.
  Eric P Tricou et al. Curr Atheroscler Rep 2023
• PCSK9 inhibition in atherosclerotic cardiovascular disease.
  Dimitrios Delialis et al. Curr Pharm Des 2023
• Genetic and Clinical Factors Underlying a Self-Reported Family History of Heart Disease.
  Amanda Jowell et al. European journal of preventive cardiology 2023

More